人类白细胞抗原G与肿瘤的发生、诊断和治疗
被引量:2
摘要
人类白细胞抗原G(HLA—G)是机体内一个重要的免疫调节分子,近年来,HLA-G与肿瘤免疫的关系得到广泛研究。最初的研究集中在HLA—G在肿瘤组织上的诱导性表达频率,如今已深入到HLA-G分子表达与肿瘤发生发展、预后、诊断以及基于HLA-G为靶点的肿瘤生物免疫治疗等方面。本文就HLA—G在上述相关领域的研究进展做一综述。
出处
《中华医学杂志》
CAS
CSCD
北大核心
2012年第2期134-136,共3页
National Medical Journal of China
基金
基金项目:国家自然科学基金(81102218、31170879)
浙江省自然科学基金(Y2101323)
参考文献40
-
1Carosella ED,Moreau P,Lemaoult J,et al.HLA-C:from biology to clinical benefits.Trends Immunol,2008,29:125-132. 被引量:1
-
2Yan WH. HLA-G expression in cancers: potential role in diagnosis,prognosis and therapy.Endocr Metab Immune Disord Drug Targets,2011,11:76-89. 被引量:1
-
3Morandi F,Ferretti E,Bocca P,et al.A novel mechanism of soluble HLA-G mediated immune modulation:downregulation of T cell chemokine receptor expression and impairment of chemotaxis.PLoS One,2010,5:e11763. 被引量:1
-
4Gregori S,Magnani CF,Roncarolo MG.Role of human leukocyte antigen-G in the induction of adaptive type 1 regulatory T cells.Hum Immunol,2009,70:966-969. 被引量:1
-
5许惠惠,颜卫华,林爱芬.HLA-G依赖的调节性细胞研究进展[J].现代免疫学,2010,30(5):432-435. 被引量:7
-
6许惠惠,阮嫣赟,颜卫华,林爱芬.HLA-G诱导DC细胞在免疫耐受机制中的研究进展[J].生命科学,2011,23(8):736-741. 被引量:7
-
7Yan WH. Human leukocyte antigen-G in cancer: are they clinically relevant? Cancer Lett,2011,311:123-130. 被引量:1
-
8Yie SM,Hu Z. Human leukocyte antigen-G (HLA-G) as a marker for diagnosis,prognosis and tumor immune escape in human malignancies.Histol Histopathol,2011,26:409-420. 被引量:1
-
9Amiot L,Ferrone S,Grosse-Wilde H,et al.Biology of HLA-G in cancer:a candidate molecule for therapeutic intervention? Cell Mol Life Sci,2011,68:417-431. 被引量:1
-
10Paul P,Rouas-Freiss N,Khalil-Daher I,et al.HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance.Proc Natl Acad Sci U S A,1998,95:4510-4515. 被引量:1
二级参考文献65
-
1Naji A, Le Rond S, Durrbach A, et al. CD3^+ CD4^low and CD3+ CD8^low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance[J]. Blood, 2007, 110:3936-3948. 被引量:1
-
2LeMaoult J, Caumartin J, Daouya M, et al. Immune regu lation by pretenders:cell to-cell transfers of HLA-G make effector T cells act as regulatory cells [J]. Blood, 2007, 109:2040-2048. 被引量:1
-
3Feger U, Tolosa E, Huang YH, et al. HLA-G expression defines a novel regulatory T -cell subset present in human pe ripheral blood and sites of inflammation [J]. Blood, 2007, 110:568-577. 被引量:1
-
4Huang YH, Zozulya AL, Weidenfeller C, etal. T cell suppression by naturally occurring HLA-G expressing regulatory CD4+ T cells is IL-10 dependent and reversible[J]. J Leukoc Biol, 2009, 86:273-281. 被引量:1
-
5Selmani Z, Naji A, Zidi I, et al. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+ CD25high Foxp3+ regulatory T cells[J]. Stem Cells, 2008, 26:212-222. 被引量:1
-
6Le Rond S, Azema C, Krawice Radanne I, et al. Evidence to support the role of HLA G5 in allograft acceptance through induction of immunosuppressive/regulatory T cells[J].J Immunol, 2006, 176:3266-3276. 被引量:1
-
7Ristich V, Liang S, Zhang W, et al. Tolerization of dendritic ceils by HLA-G[J]. Eur J Immunol, 2005, 35:1133- 1142. 被引量:1
-
8Ristich V, Zhang W, Liang S, et al. Mechanisms of pro longation of allograft survival by HLA G/ILT4-modified dendritic cells[J]. Hum Immunol, 2007, 68:264-271. 被引量:1
-
9Yan WH, I.in A, Chen BG, etal. Induction of both merebrane-bound and soluble HLA-G expression in active human cytomegalovirus infection[J]. J Infect Dis, 2009, 200:820-826. 被引量:1
-
10Curiel TJ. Tregs and rethinking cancer immunotherapy[J].J Clin Invest, 2007, 117:1167-1174. 被引量:1
共引文献12
-
1许惠惠,阮嫣赟,颜卫华,林爱芬.HLA-G诱导DC细胞在免疫耐受机制中的研究进展[J].生命科学,2011,23(8):736-741. 被引量:7
-
2徐丹萍,颜卫华.HLA-G与HIV病毒感染的研究进展[J].现代免疫学,2011,31(6):517-520. 被引量:2
-
3徐亦君,竺明晨.HLA-G在结肠癌外周血中的表达及其临床意义[J].中国肿瘤外科杂志,2011,3(6):348-350. 被引量:1
-
4徐丹萍,林爱芬,颜卫华.HLA-G与自身免疫病相关性研究进展[J].生命科学,2012,24(3):217-222. 被引量:7
-
5许惠惠,林爱芬,颜卫华.ILT受体在HLA-G参与免疫耐受机制中的研究进展[J].生命科学,2012,24(7):640-645. 被引量:1
-
6宋斌,万楚成,章正华,李章志,陈雁.自身免疫性溶血性贫血患者血清可溶性人类白细胞抗原G水平测定及意义[J].中华实用诊断与治疗杂志,2013,27(11):1066-1067. 被引量:1
-
7宋斌,章正华,陈雁,万楚成.急性白血病患者血清sHLA-G水平测定的临床意义[J].现代肿瘤医学,2013,21(12):2801-2803.
-
8徐喜龙,郭晓光,王龙龙.HLA-G在部分头颈部恶性肿瘤中表达研究进展[J].中国卫生产业,2014,11(4):189-191.
-
9宋斌,章正华,李章志,陈雁,万楚成.慢性特发性血小板减少性紫癜患者血清sHLA-G水平测定的临床意义[J].湖南中医药大学学报,2014,34(2):1-1. 被引量:4
-
10许惠惠,林爱芬,颜卫华.人类白细胞抗原-G与人乳头瘤病毒致宫颈癌相关性研究进展[J].中国实用妇科与产科杂志,2014,30(3):228-230. 被引量:3
同被引文献62
-
1马薇,周昌菊.HLA-G多态性在生殖领域的研究进展[J].国际病理科学与临床杂志,2006,26(3):259-262. 被引量:6
-
2薛松果,杨珏琴,姚芳娟,许玲娣,范丽安.正常妊娠和原因不明习惯性流产者HLA-G基因14bp缺失多态性研究[J].现代免疫学,2006,26(4):318-321. 被引量:12
-
3孙玉英,奚永志.我国大陆人群HLA新等位基因发现的现状及应注意的问题[J].中华医学杂志,2006,86(32):2233-2235. 被引量:23
-
4Konno R. Screening of uterine cervical neoplasms and HPV vac- cine[J]. Gan To Kagaku Ryoho, 2013, 40(2): 165-169. 被引量:1
-
5Lajoie J, Jeanneau A, Faucher MC, et al. Characterisation of five novel HLA-G alleles with coding DNA base changes [ J ]. Tissue Antigens, 2008, 72(5) : 502-504. 被引量:1
-
6Rousseau P, Le Discordc M, Mouillot G, et al. The 14 bp dele- tion-insertion polymorphism in the 30 UTregion of the HLA-G gene influences HLA-G mRNA stability [ J ]. Hum Immunol, 2003, 64 ( 11 ) : 1005-1010. 被引量:1
-
7Hviid TV, Hylenius S, Rorbye C, et al. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform pro- file and HLA-G mRNA levels[ J]. Immunogenetics, 2003, 55 (2) : 63-79. 被引量:1
-
8Chen XY, Yan WH, Lin A, et al. The 14 bp deletion polymor- phisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma [ J ]. Tissue Antigens, 2008, 72 (4) : 335-341. 被引量:1
-
9Dong D, Yang H, Li K, et al. Human leukocyte antigen-G (HLA-G) expression in cervical lesions: association with cancer progression, HPV 16/18 infection, and host immune response [J]. Reprod Sei, 2010, 17(8) : 718-723. 被引量:1
-
10Gasit E, Sherf M, Balbin E, et al. HLA-G expression is in- duced in Epstein-Barr virus-transformed B-cell lines by culture conditions[J]. Hum Immunol, 2007, 68(6): 463-468. 被引量:1
二级引证文献3
-
1吴红展,胡逸君,张爱娜.重组人干扰素α-2a栓治疗宫颈人乳头瘤病毒亚临床感染[J].中国基层医药,2014,21(14):2166-2168. 被引量:3
-
2彭小星,赵刚.多层螺旋CT在宫颈癌淋巴结转移诊断中的应用价值[J].中国妇幼保健,2017,32(24):6319-6321. 被引量:6
-
3邓杨富,欧阳辉,陆桂宁.高危型HPV DNA联合TCT检测在宫颈癌初筛中的价值研究[J].中国妇幼卫生杂志,2018,9(1):66-68. 被引量:5
-
1李霞,郑振群.NO───种新发现的免疫调节分子[J].免疫学杂志,1996,12(3):201-204. 被引量:20
-
2吴俊东,沈文律.一氧化氮与移植器官排斥反应[J].汕头大学医学院学报,2001,14(4):280-282. 被引量:1
-
3汪峰,陈忠华.Tim-3,一个Th1相关的免疫调节分子[J].现代免疫学,2007,27(2):169-172. 被引量:4
-
4余传霖.哺乳动物Toll样受体对结核分枝杆菌的控制[J].国外医学(微生物学分册),2003,26(6):29-29.
-
5杨阳,于益芝.吲哚2,3-双加氧酶作为信号分子参与免疫耐受的调节[J].中国肿瘤生物治疗杂志,2012,19(3):238-238.
-
6刘培军.穿孔素研究进展[J].国外医学(免疫学分册),2002,25(2):69-72.
-
7开展肿瘤自体免疫细胞治疗技术——奋进中的宁夏人民医院血液肿瘤内科及肿瘤生物治疗中心[J].宁夏医学杂志,2014,36(10).
-
8颜卫华,范丽安.HLA-G与移植免疫[J].免疫学杂志,2004,20(z1):1-3. 被引量:2
-
9方慧云,程伟民,季明芳.WT1抗原负载的DC联合CIK对鼻咽癌细胞的体外杀伤活性研究[J].黑龙江医学,2015,39(7):731-732. 被引量:1
-
10夏海滨,金伯泉.细胞因子分子克隆方法的研究进展[J].单克隆抗体通讯,1995,11(3):103-107.